We have named the anti-in‰ammatory benzoic acid derivatives with terpene moieties from Myrsine seguinii as myrsinoic acids. Abbreviations : TPA, 12-O-tetradecanoyl-phorbol-13-acetate; MM2, molecular mechanics 2; MTPA, a-methoxy-a-(tri‰uoromethyl) phenylacetic acid Biosci. Biotechnol. Biochem., 66 (3), [655][656][657][658][659] 2002 Note Myrsinoic Acids B, C and F, Anti-in‰ammatory Compounds from Myrsine seguinii The methanolic extract of Myrsine seguinii yielded three anti-in‰ammatory compounds, myrsinoic acids B, C and F, and their structures were elucidated from the spectroscopic data. These compounds suppressed the TPA-induced edema of mouse ear, myrsinoic acid F being the most active (IE 77% at a dose of 0.56 mmol).
Skin tumor promoters such as 12-Otetaradecanoylphorbol-13-acetate (TPA) induce edema on the skin with cell proliferation. 1, 2) Inhibitors of TPA-induced edema can be expected to suppress various physiological responses involving cell proliferation as well as in‰ammation. With the objective ofˆnding new types of anti-in‰ammatory compounds, we have been searching for compounds from plants which would suppress TPA-induced edema. The methanolic extract of Myrsine seguinii of the Myrsinaceae family contained 5-geranyl-4-hydroxy-5-(3?-methyl-2?-butenyl)-benzoic acid (myrsinoic acid A) which we have recently isolated as an anti-in‰ammatory compound.
3) Mizushina et al. have found that this compound also inhibited DNA polymerase. 4) In our continuing search for other anti-in‰ammatory compounds from this plant, we isolated three related compounds, myrsinoic acids B, C and F (Fig. 1 ). This paper reports the structures and anti-in‰ammatory activities of these compounds.
Fresh leaves and twigs of M. seguinii (12 kg) were extracted with methanol. After removing the solvent, the extract was successively partitioned with hexane W water and ethyl acetate W water. Marked activity was found in the hexane-soluble part (72 g, IE 94z at a dose of 2 mg) and ethyl acetate-soluble part (69 g, IE 49z at a dose of 2 mg). The ethyl acetate-soluble part was puriˆed by silica gel and ODS column chromatography to give myrsinoic acid B (494 mg) and myrsinoic acid C (145 mg) as anti-in‰ammatory compounds. We had already isolated myrsinoic acid A (63 mg), 3) from the hexane soluble part and this was further puriˆed by silica gel chromatography and HPLC to also give myrsinoic acid F (3.2 mg).
The HR-EIMS analysis of myrsinoic acid B gave the molecular formula of C22H30O4 with eight unsaturations. This molecular formula was corroborated by the 13 C-NMR spectral data ( Table 1) . The IR spectrum displayed prominent absorptions at 3400 cm "1 (OH), at 3200-2400 cm "1 and 1680 cm "1 (COOH), and at 1600 cm "1 (C＝C). The 13 C-NMR spectrum was similar to that of myrsinoic acid A, 3) with the exception of additional oxygen-bearing carbons (89.6 and 73.8 ppm) and the number of oleˆnic carbons. Myrsinoic acid B had ten oleˆnic carbons including benzene ring carbons (162. 4 The molecular formula of myrsinoic acid C was established as C22H30O4 by the HR-EIMS data. The IR spectrum showed the absorption bands of a hydroxyl group (3400 cm "1 ), a carboxyl group (3200-2400 cm "1 , 1670 cm "1 ) and a double bond(s) (1600 cm "1 ). The 1 H-and 13 C-NMR spectra are similar to those of myrsinoic acid B. The diŠerences between the spectra for myrsinoic acids B and C are the protons and carbon chemical shifts in the 1 H-and 13 C-NMR data. 2D NMR of myrsinoic acid C, including COSY, HMQC and HMBC revealed the presence of a dihydro-chroman ring with a hydroxyl at C3 as shown in Figs. 2 and 3 . The signal of the oxymethine proton at C3 was found at dH 3.92 (dd, J ＝4.9, 6.4 Hz). The Carplus rule predicted that the dihedral angles of H3-C3-C4-H4a and H3-C3-C4-H4b were ca. 409and 509 , respectively. The MM2 calculation for the C3-epimers (2,3-cis-or 2,3-trans-isomers) of myrsinoic acid C led to the elucidation of each stable conformation. The dihedral angles of H3-C3-C4-H4a and H3-C3-C4-H4b were respectively 449and 749in the cis-2,3-isomer, and 1679and 909in the trans-2,3-isomer. These results indicate that myrsinoic acid C had the cis-2,3 conˆguration. Furthermore, the NOESY spectrum exhibited NOE correlation signals between a methyl at C-2 and a methine at C3, thus conˆrming this cis-2,3 conˆguration.
An asymmetric center at C3 was established to be of S conˆguration by using the modiˆed Mosher's method 6) as shown in Fig. 4 . Therefore, another asymmetric center at C2 also had the S conˆguration.
Thus, myrsinoic acid C was established as (2S ),(3S )-6-carboxy-2,3-dihydro-3-hydroxy-2-methyl-2-(4?-methylpenta-3?-enyl)-8-(3!-methyl-2!-butenyl)-chroman.
The molecular formula of myrsinoic acid F was established as C 22 H 28 O 3 by the HR-EIMS data. This molecular formula corresponds to that of a dehydrate of myrsinoic acid B or C. The 1 H-NMR and 13 C-NMR spectra exhibited signals for a benzene ring, 3-methyl-2-butenyl, carboxyl and two double bonds as shown in Table 1 . The 1 H-NMR spectrum suggested a structure similar to that of myrsinoic acid B, diŠering only in the 1,5-dimethyl-1-hydroxy-4-hexenoyl moiety. An analysis of the COSY and HMBC spectra revealed the presence of a double bond at C1? as shown in Figs. 2 and 3 . The NOESY spectrum showed NOE correlation signals between a methyl at C1? (H37?) and a methylene (H23?), indicating that the C1? double bond was of E conˆguration. This conˆguration is also supported by the fact that the C7? methyl appeared at a high magneticˆeld (dC 12.1) in the 13 C-NMR spectrum. 7) Thus, myrsinoic acid F was elucidated to be 5-carboxy-2,3-dihydro-2-(l?,5?-dimethyl-1?E,4?-hexadienyl)-7-(3!-methyl-2!- In parentheses: SE. A sample (1.4 mmol or 0.56 mmol) was applied on one mouse ear and, after 30 min, TPA (0.5 mg) was applied to both ears of the mouse. The edema was evaluated after 7 hr, inhibitory eŠect being expressed as the percentage ratio of the edema. Five mice were used for each experiment. *Signiˆcantly diŠerent, Pº0.05, in the Student's t-test.
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butenyl)benzofuran.
The isolated compounds were subjected to the mouse ear anti-in‰ammatory test. 8) At a dose of 1.4 mmol, myrsinoic acids A, B and C suppressed TPAinduced in‰ammation by up to 65z, 83z and 68z, respectively. At a dose of 0.56 mmol, myrsinoic acids A, B and C exhibited IE value of 22z, 25z and 44z, respectively. These activities are comparable to those of indomethacin. Myrsinoic acid F inhibited 77z of the in‰ammation with a 0.56-mmol application. The activity of myrsinoic acid F was stronger than that of indomethacin, the normally used antiin‰ammatory agent.
In conclusion, we isolated three additional antiin‰ammatory compounds toward TPA-induced edema, myrsinoic acid B, C and F, from Myrsine seguinii. Among them, myrsinoic acid F showed the strongest activity. We expect myrsinoic acids to suppress various physiological responses concerned with cell proliferation.
Experimental
Instruments. The following instruments were used: a Bruker DR500 FT-NMR spectrometer for the 1 Hand 13 C-NMR spectra, Hitachi JX 2000 and JEOL JMS 700 mass spectrometers for the mass spectra, and a JASCO IR spectrometer for the IR spectra.
Anti-in‰ammatory test. The mouse in‰ammatory test was conducted by Gschwendt's method. 8) This experiment complied with the regulations concerning animal experimentation and the care of experimental animals of the Faculty of Agriculture at Shinshu University.
Isolation of myrsinoic acid B and C. Fresh leaves and twigs of M. seguinii (12 kg) were soaked in methanol, and the resulting methanolic extract was concentrated in vacuo. The aqueous solution was successively partitioned with hexane W water and ethyl acetate W water. The hexane-soluble part (72 g) and the ethyl acetate-soluble part (69 g) both showed strong activity. The ethyl acetate-soluble part was chromatographed in a silica gel column with hexane W ethyl acetate by 10z stepwise elution to obtain twelve fractions. The fraction eluted with 40z ethyl acetate W hexane (3.17 g) was further chromatographed in an ODS column (YMC gel ODS-AM 120-S50) with gradient elution from 50z methanol W water to methanol. Each 9 ml of the eluate was collected in a test tube. Fractions No. 19-28 were further puriˆed in a silica gel column with 10z acetone W benzene to give myrsinoic acids B (oil, 494 mg) and C (oil, 145 mg). Table 1 .
MTPA esters of the myrsinoic acid C methyl ester. Myrsinoic acid C was dissolved in methanol and then treated with a diazomethane ethereal solution. The reaction mixture was kept at 49 C overnight, and then evaporated to quantitatively give a methyl ester.
The myrsinoic acid C methyl ester (6.2 mg) was dissolved in 1 ml of dry methylene chloride. The solution was treated with triethylamine (10 ml), dimethylaminopyridine (10 mg) and (S )-(+)-MTPA chloride (10 ml), the solution then being allowed to stand at room temperature for 24 hours. The reaction mixture was next poured into ice-cooled water and taken up with ethyl acetate. The ethyl acetate layer was successively washed with water, 1 N HCl, aqueous sodium bicarbonate, and water. The solution was dried over anhydrous magnesium sulfate andˆltered, and the resultingˆltrate was evaporated to yield 9.3 mg of the (R)-MTPA ester of the myrsinoic acid C methyl ester (99z yield).
With (R)-(")-MTPA chloride, the myrsinoic acid C methyl ester (9.0 mg) was esteriˆed in the same manner to yield 13. 
